H.I.G. Capital completed a strategic equity investment via one of its affiliates into Rising Pharma Holdings and Casper Pharma, owner of generic and specialty drugmaker Rising Pharmaceuticals. The value of the transaction was not disclosed.
Rising Pharmaceuticals operates with an asset-light model, focusing on the development, regulatory and marketing aspects of the product life cycle while outsourcing manufacturing to a network of 23 strategic partners. The company is based in New Brunswick, New Jersey, and currently has a diversified portfolio of more than 125 products.
H.I.G. has partnered with Rising . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content and benefits including daily/weekly/monthly newsletters.
Monthly
$30
A pay-as-you-go plan to get you started
→ Instantly unlock all new and archived articles
→ Daily, weekly and monthly e-mail newsletters
→ Access to the weekly AW Deal Watch by AW Research
Annual
$300
Get more for less - 20% discount over monthly
→ Everything in Monthly PLUS:
→ Access to articles and data from AW Research
→ AW Annual Investor Compendium – our comprehensive guide to investor activity, with a ranking of the most active investors for the year and profiles of the top global allocators
